Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
(Q82294729)
scientific article published on 14 October 2008
scientific article published on 14 October 2008
Language:
Current Data About
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
other details
| description | scientific article published on 14 October 2008 |
External Links
| (P356) |
10.1200/JCO.2008.16.3212
|
| (P698) |
18854571
|